[1] ENGELMANN MD, SVENDSEN JH. Inflammation in the genesis and perpetuation of atrial fibrillation[J]. Eur Heart J, 2005, 26(20): 2083. doi: 10.1093/eurheartj/ehi350
[2] DU X, GUO L, XIA S, et al. Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China[J]. Heart, 2021, 107(7): 535. doi: 10.1136/heartjnl-2020-317915
[3] MICHNIEWICZ E, MLODAWSKA E, LOPATOWSKA P, et al. Patients with atrial fibrillation and coronary artery disease-double trouble[J]. Adv Med Sci, 2018, 63(1): 30. doi: 10.1016/j.advms.2017.06.005
[4] 郭宇闻, 杨登法, 杨铁军, 等. 扩散张量成像联合美国国立卫生研究院卒中量表评价老年急性脑梗死患者预后价值[J]. 中华老年心脑血管病杂志, 2018, 20(10): 1054. doi: 10.3969/j.issn.1009-0126.2018.10.012
[5] 靳佳敏, 马翠红, 范昆鹏, 等. 血浆NLR、PLR及其联合指标对脑梗死溶栓患者预后的预测价值[J]. 临床荟萃, 2020, 35(3): 228. doi: 10.3969/j.issn.1004-583X.2020.03.007
[6] CHENG X, LIU L, LI L, et al. Significance of CHA2DS2-VASC on the severity and hemorrhagic transformation in patients with non-valvular atrial fibrillation-induced acute ischemic stroke[J]. Intern Emerg Med, 2021, 16(5): 1155. doi: 10.1007/s11739-020-02558-y
[7] KUSZNIR VITTURI B, JOSÉ GAGLIARDI R. Use of CHADS2 and CHA2DS2-VASc scores to predict prognosis after stroke[J]. Rev Neurol (Paris), 2020, 176(1/2): 85.
[8] MERLINO G, RANA M, NALIATO S, et al. CHA2DS2-VASc score predicts short- and long-term outcomes in patients with acute ischemic stroke treated with intravenous thrombolysis[J]. J Thromb Thrombolysis, 2018, 45(1): 122. doi: 10.1007/s11239-017-1575-0
[9] 聂慧, 禹玲. 老年急性缺血性脑卒中静脉溶栓患者NIHSS评分与不良预后的相关性研究[J]. 老年医学与保健, 2021, 27(5): 955. doi: 10.3969/j.issn.1008-8296.2021.05.015
[10] 韩楠楠, 常明则, 张格娟, 等. 侧支代偿联合NIHSS评分预测大脑中动脉闭塞患者的预后[J]. 卒中与神经疾病, 2019, 26(1): 60.
[11] SALAS-PERDOMO A, MIRO-MUR F, URRA X, et al. T cells prevent hemor- rhagic transformation in ischemic stroke by P-selectin binding[J]. Arterioscler Thromb Vasc Biol, 2018, 38(8): 1761. doi: 10.1161/ATVBAHA.118.311284
[12] KIM J, SONG TJ, PARK JH, et al. Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction[J]. Atherosclerosis, 2012, 222(2): 464. doi: 10.1016/j.atherosclerosis.2012.02.042
[13] ZOU F, WANG J, HAN B, et al. Early neutrophil-to-lymphocyte ratio is a prognostic marker in acute ischemic stroke after successful revascularization[J]. World Neurosurg, 2022, 157: e401. doi: 10.1016/j.wneu.2021.10.097
[14] QUAN K, WANG A, ZHANG X, et al. Neutrophil to lymphocyte ratio and adverse clinical outcomes in patients with ischemic stroke[J]. Ann Transl Med, 2021, 9(13): 1047. doi: 10.21037/atm-21-710
[15] MAJID S, LODHI OUH, NIAZI AK, et al. Usefulness of neutrophil-to-lymphocyte ratio as a predictor of functional outcome in patients with acute ischemic stroke after thrombolysis therapy[J]. Proc (Bayl Univ Med Cent), 2021, 34(6): 664.
[16] YING Y, YU F, LUO Y, et al. Neutrophil-to-lymphocyte ratio as a predictive biomarker for stroke severity and short-term prognosis in acute ischemic stroke with intracranial atherosclerotic stenosis[J]. Front Neurol, 2021, 12: 705949. doi: 10.3389/fneur.2021.705949